Overview
Focus on the fields of medical technology and health consumption; after joining Yuanjing, the leading investment projects include Pharmaceutical Research Society, Huamai Tech, Fourier Intelligence, NeoX Xingkangyuan, Genesis Biology, Jiaqian Medical, Innovac, etc.; previous investment projects include Ruibao Pediatrics, Meinian University Health, Ma Wei Dental, etc.; former vice president of Jiyuan Capital; and MBA of UCLA Anderson Business School.
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
重点关注医疗科技和健康消费领域；加入元璟后主导投资项目包括药研社、华脉泰科、傅利叶智能、NeoX星亢原、寻因生物、佳量医疗、因诺纬克等；此前投资项目包括睿宝儿科、美年大健康、马泷齿科等；曾任纪源资本副总裁；加州大学洛杉矶分校安德森商学院MBA。